M. Dedavid et al., NEUROCUTANEOUS MELANOSIS - CLINICAL-FEATURES OF LARGE CONGENITAL MELANOCYTIC NEVI IN PATIENTS WITH MANIFEST CENTRAL-NERVOUS-SYSTEM MELANOSIS, Journal of the American Academy of Dermatology, 35(4), 1996, pp. 529-538
Background: Patients with a large congenital melanocytic nevus (LCMN)
may have associated leptomeningeal melanocytosis with or without centr
al nervous system (CNS) melanomas. These patients are considered to ha
ve neurocutaneous melanosis, a disorder that, when symptomatic or othe
rwise manifest neurologically, carries a poor prognosis even in the ab
sence of malignancy. Objective: Our purpose was to identify typical cl
inical features in patients who have manifest CNS melanosis in associa
tion with LCMN. Methods: The records of 117 patients with LCMN in the
New York University Registry of LCMN and the reports of 172 cases of L
CMN in the world Literature were included for features that might sign
al a high risk for the development of manifest CNS involvement. Result
s: Of the 289 patients with LCMN, 33 had manifest CNS melanosis. In al
l 33 in whom symptomatic neurocutaneous melanosis was diagnosed, the L
CMNs were present in a posterior axial location on the head, neck, bac
k, and/or buttocks. ''Satellite'' nevi were known to be present in 31
of the 33 patients. Conclusion: Patients with LCMN in a posterior axia
l location, especially when associated with ''satellite'' melanocytic
nevi, are at greater risk for the development of manifest neurocutaneo
us melanosis than patients with LCMN limited to the extremities or tho
se who are lacking satellite nevi.